文献速递慢性肾脏病

贫血与退伍军人新发慢性肾脏病患者痴呆风险的关系

Role of Anemia in Dementia Risk Among Veterans With Incident CKD.
PubMed 文献 · Am J Kidney Dis · 2023-07-28

该回顾性队列研究纳入2005年至2016年间美国退伍军人健康管理局系统中620,095例新发3期慢性肾脏病(CKD)的退伍军人。在中位4.1年随访期间,15%的参与者发生痴呆。与无贫血者相比,轻度贫血和 moderate/severe 贫血者痴呆风险分别升高16%(95% CI 14%-17%)和27%(95% CI 23%-31%),复合终点(肾衰竭或死亡)风险分别升高39%(95% CI 37%-40%)和115%(95% CI 112%-119%)。

要点

  • 在新发3期CKD退伍军人中,贫血与痴呆风险升高显著相关。
  • 轻度贫血者痴呆风险升高16%,中/重度贫血者升高27%。
  • 贫血亦与肾衰竭或死亡复合终点风险升高相关。

核心结论

  • 在新发CKD退伍军人中,贫血与痴呆风险升高显著相关,提示贫血可作为痴呆风险的预测因素。

研究设计与样本

  • 回顾性队列研究,纳入2005年1月至2016年12月美国退伍军人健康管理局系统中620,095例年龄≥45岁、新发3期CKD(eGFR<60mL/min/1.73m2)的退伍军人,随访至2018年12月31日。

主要发现

  • 中位随访4.1年期间,92,306例(15%)在肾衰竭或死亡前发生痴呆。
  • 与无贫血者相比,轻度贫血者痴呆风险升高16%(95% CI 14%-17%),中/重度贫血者升高27%(95% CI 23%-31%)。
  • 与无贫血者相比,轻度贫血者肾衰竭或死亡复合风险升高39%(95% CI 37%-40%),中/重度贫血者升高115%(95% CI 112%-119%)。

关键数值与推荐

  • 贫血定义基于新发CKD诊断前2年平均血红蛋白水平:女性正常≥12.0g/dL、轻度11.0-11.9g/dL、中/重度<11.0g/dL;男性正常≥13.0g/dL、轻度11.0-12.9g/dL、中/重度<11.0g/dL。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 观察性研究设计存在残余混杂。
  • 研究结果可能无法推广至更广泛的美国人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Although some evidence exists of increased dementia risk from anemia, it is unclear whether this association persists among adults with CKD. Anemia may be a key marker for dementia among adults with CKD, so we evaluated whether anemia is associated with an increased risk of dementia among adults with CKD. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: The study included 620,095 veterans aged≥45 years with incident stage 3 CKD (estimated glomerular filtration rate [eGFR]<60mL/min/1.73m2) between January 2005 and December 2016 in the US Veterans Health Administration system and followed through December 31, 2018, for incident dementia, kidney failure, or death. EXPOSURE: Anemia was assessed based on the average of hemoglobin levels (g/L) during the 2 years before the date of incident CKD and categorized as normal, mild, or moderate/severe anemia (≥12.0, 11.0-11.9,<11.0g/dL, respectively, for women, and≥13.0, 11.0-12.9,<11.0g/dL for men). OUTCOME: Dementia and the composite outcome of kidney failure or death. ANALYTICAL APPROACH: Adjusted cause-specific hazard ratios were estimated for each outcome. RESULTS: At the time of incident CKD, the mean age of the participants was 72 years, 97% were male, and their mean eGFR was 51mL/min per 1.73m2. Over a median 4.1 years of follow-up, 92,306 veterans (15%) developed dementia before kidney failure or death. Compared with the veterans with CKD without anemia, the multivariable-adjusted models showed a 16% (95% CI, 14%-17%) significantly higher risk of dementia for those with mild anemia and a 27% (95% CI, 23%-31%) higher risk with moderate/severe anemia. Combined risk of kidney failure or death was higher at 39% (95% CI, 37%-40%) and 115% (95% CI, 112%-119%) for mild and moderate/severe anemia, respectively, compared with no anemia. LIMITATIONS: Residual confounding from the observational study design. Findings may not be generalizable to the broader US population. CONCLUSIONS: Anemia was significantly associated with an increased risk of dementia among veterans with incident CKD, underscoring the role of anemia as a predictor of dementia risk. PLAIN-LANGUAGE SUMMARY: Adults with chronic kidney disease (CKD) often have anemia. Prior studies among adults in the general population suggest anemia is a risk factor for dementia, though it is unclear whether this association persists among adults with CKD. In this large study of veterans in the United States, we studied the association between anemia and the risk of 2 important outcomes in this population: (1) dementia and (2) kidney failure or death. We found that anemia was associated with a greater risk of dementia as well as risk of kidney failure or death. The study findings therefore emphasize the role of anemia as a key predictor of dementia risk among adults with CKD.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Koyama AK, Nee R, Yu W, et al. Role of Anemia in Dementia Risk Among Veterans With Incident CKD. Am J Kidney Dis. 2023. PMID: 37516301. doi:10.1053/j.ajkd.2023.04.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。